Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

MUCOSAL IMMUNOLOGY IN 2019

Immune recognition of microbial metabolites

Nature Reviews Immunology volume 20, pages 91–92 (2020)Cite this article

Subjects

Mucosal immunology research continues its fascination with microbial metabolites. In 2019, researchers uncovered extended functions for microbial metabolites in immunity, deepening our understanding of the regulation and function of metabolite-reactive immune cells, and revealed the receptors by which immune cells can recognize bioactive microbial metabolites.

Key advances

  • Short-chain fatty acids affect host defence by acting on group 3 innate lymphoid cells via free fatty acid receptor 2 (FFAR2), on macrophages through metabolic reprogramming and on memory CD8+ T cells through an FFAR2-dependent and FFAR3-dependent shift in T cell metabolism.

  • Screens have revealed microbial metabolites that activate G protein-coupled receptors (GPCRs) affecting numerous host physiological processes.

  • Mucosal-associated invariant T (MAIT) cells rely on early life bacterial exposures for their development, and skin-resident MAIT cells play crucial roles in tissue repair.

  • Effective mining of public resources of microbial metabolites, GPCR–metabolite interactions and immune cell transcriptomes is accelerating the pace of discovery and translation of immune–microbial metabolite interactions for promoting health and mitigating disease.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Interactions between microbial metabolites and immune cells.

References

  1. Chun, E. et al. Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity. Immunity https://doi.org/10.1016/j.immuni.2019.09.014 (2019).

    Article  PubMed  Google Scholar 

  2. Bachem, A. et al. Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8+ T cells. Immunity 51, 285–297 (2019).

    Article  CAS  Google Scholar 

  3. Schulthess, J. et al. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity 50, 432–445 (2019).

    Article  CAS  Google Scholar 

  4. Skelly, A. N. et al. Mining the microbiota for microbial and metabolite-based immunotherapies. Nat. Rev. Immunol. 19, 305–323 (2019).

    Article  CAS  Google Scholar 

  5. Morita, N. et al. GPR31-dependent dendrite protrusion of intestinal CX3CR1+ cells by bacterial metabolites. Nature 566, 110–114 (2019).

    Article  CAS  Google Scholar 

  6. Colosimo, D. A. et al. Mapping interactions of microbial metabolites with human G-protein-coupled receptors. Cell Host Microbe 26, 273–282.e7 (2019).

    Article  CAS  Google Scholar 

  7. Chen, H. et al. A forward chemical genetic screen reveals gut microbiota metabolites that modulate host physiology. Cell 177, 1217–1231 (2019).

    Article  CAS  Google Scholar 

  8. Constantinides, M. G. et al. MAIT cells are imprinted by the microbiota in early life and promote tissue repair. Science 366, eaax6624 (2019).

    Article  CAS  Google Scholar 

  9. Legoux, F. et al. Microbial metabolites control the thymic development of mucosal-associated invariant T cells. Science 366, 494–499 (2019).

    Article  CAS  Google Scholar 

  10. Godfrey, D. I. et al. The biology and functional importance of MAIT cells. Nat. Immunol. 20, 1110–1128 (2019).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The author thanks members of the Garrett laboratory for stimulating discussions. Work related to this piece is supported by the US National Institutes of Health (R01CA154426 and R24DK11049).

Author information

Authors and Affiliations

  1. Departments of Immunology & Infectious Diseases and Molecular Metabolism, Harvard T. H. Chan School of Public Health; Dana-Farber Cancer Institute; Broad Institute and Harvard Medical School, Boston, MA, USA

    Wendy S. Garrett

Authors
  1. Wendy S. Garrett
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wendy S. Garrett.

Ethics declarations

Competing interests

The author is a member of the scientific advisory boards of Kintai Therapeutics, Leap Therapeutics, Evelo Biosciences and Tenza.

Additional information

RELATED LINK

Human Microbiome Bioactives Resource (HMBR): https://www.microbiome-bioactives.org/

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Garrett, W.S. Immune recognition of microbial metabolites. Nat Rev Immunol 20, 91–92 (2020). https://doi.org/10.1038/s41577-019-0252-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41577-019-0252-2

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing